Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review

oleh: Siddhartha Sood, HBSc, Ahmed Bagit, BSc, Martin Heung, Khalad Maliyar, MD, Abrahim Abduelmula, MD, Muskaan Sachdeva, MD, Jorge R. Georgakopoulos, MD, Asfandyar Mufti, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

Format: Article
Diterbitkan: Elsevier 2024-09-01

Deskripsi

Subjek

abrocitinib; atopic dermatitis; baricitinib; dupilumab; evidence-based; Janus kinase inhibitor